{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:59Z","timestamp":1787169599514,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Opportunistic fungal infections like Mucormycosis in Coronavirus Disease 2019 (COVID-19) patients have posed a great challenge to health care professionals, especially in developing countries like India. Hence, there is a need to understand the biological behaviour of COVID-19 associated Mucormycosis (CAM) to establish standard treatment Protocols and to reduce mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aims is to assess the type of Mucormycosis among COVID-19 patients in study population and compare the findings with clinical, radiological and haematological parameters along with treatment and surgical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>This retrospective, observational study included 60 cases of CAM reported to the Department of Oral and Maxillofacial Surgery at the tertiary care centre, Karnataka Institute of Medical Sciences, Hubli. Data about various parameters were tabulated and analysed statistically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Bivariate analysis was done using the Chi-Square test to assess the relationship between the type of Mucormycosis and other variables. Spearman's Correlation test was used to assess the correlation between types of Mucormycosis with the other variables. Linear regression analysis was performed to assess the response variable related to the type of Mucormycosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      About 50% of subjects presented with \u201cRhino orbital\u201d type of Mucormycosis. Palatal discoloration and palatal erosion was the most common oral manifestation among \u201conly Sinus\u201d and \u201cRhino orbital\u201d types of Mucormycosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.00). Significant association (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.29) was found between the type of Diabetes mellitus and Mucormycosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The study indicates that DM is the most commonly associated comorbidity in CAM patients. Hence, a thorough understanding of the underlying comorbidity and its close monitoring during and after COVID-19 infection is mandatory for successful treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_152_22","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:27:46Z","timestamp":1682486866000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 Associated Mucormycosis (CAM)"],"prefix":"10.4103","volume":"26","author":[{"given":"Manjunath M.","family":"Vijapur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanth","family":"Kattimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VK","family":"Varsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HC","family":"Girish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamata","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240906","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/ciab726","article-title":"COVID-19 associated Mucormycosis (CAM): Risk factors and mechanisms of disease","volume":"74","author":"Narayanan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R2-5-20240906","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World","volume":"186","author":"Muthu","year":"2021","journal-title":"Mycopathologia"},{"key":"R4-5-20240906","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Review Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"J Clin Infect Dis"},{"key":"R5-5-20240906","first-page":"20499361211027065","article-title":"COVID-19 associated mucormycosis: The urgent need to reconsider the indiscriminate use of immunosuppressive drugs","volume":"18","author":"Rodriguez-Morales","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"R6-5-20240906","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"R7-5-20240906","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/0970-9290.84313","article-title":"Sequence of oral manifestations in rhino-maxillary mucormycosis","volume":"22","author":"Doni","year":"2011","journal-title":"Indian J Dent Res"},{"key":"R8-5-20240906","first-page":"31","article-title":"COVID-19-associated mucormycosis of head-and-neck region: A systematic review","volume":"8","author":"Kamat","year":"2022","journal-title":"J Clin Transl Res"},{"key":"R9-5-20240906","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12663-021-01604-2","article-title":"Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: A comprehensive review","volume":"20","author":"Jose","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"R10-5-20240906","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: A tale of two pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R11-5-20240906","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/QCO.0000000000000008","article-title":"Update on mucormycosis pathogenesis","volume":"26","author":"Ibrahim","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"R12-5-20240906","first-page":"e15820","article-title":"COVID-19 coinfection with mucormycosis in a diabetic patient","volume":"13","author":"Roopa","year":"2021","journal-title":"Cureus"},{"key":"R13-5-20240906","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jof8010044","article-title":"Dental and oral manifestations of COVID-19 related mucormycosis: Diagnoses, management strategies and outcomes","volume":"3","author":"Janjua","year":"2021","journal-title":"J Fungi (Basel"},{"key":"R14-5-20240906","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.clinthera.2018.03.009","article-title":"Recent Advances in the pathogenesis of mucormycoses","volume":"40","author":"Petrikkos","year":"2018","journal-title":"Clin Ther"},{"key":"R15-5-20240906","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J Med Cases"},{"key":"R16-5-20240906","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: Understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-5-20240906","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"R18-5-20240906","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"R19-5-20240906","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R20-5-20240906","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: Pathophysiology, presentation, and management","volume":"8","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R21-5-20240906","first-page":"e13163","article-title":"A case of fatal rhino- orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19","volume":"13","author":"Waizel-Haiat","year":"2021","journal-title":"Cureus"},{"key":"R22-5-20240906","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A Multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R23-5-20240906","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"30","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R24-5-20240906","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.crad.2021.07.004","article-title":"Imaging of COVID-19-associated craniofacial Mucormycosis: A black and white review of the \u201cblack fungus","volume":"76","author":"Sanghvi","year":"2021","journal-title":"Clinical Radiology"},{"key":"R25-5-20240906","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-020-02374-0","article-title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"R26-5-20240906","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-2143(99)90066-5","article-title":"Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis","volume":"133","author":"Cantinieaux","year":"1999","journal-title":"J Lab Clin Med"},{"key":"R27-5-20240906","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"R28-5-20240906","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","article-title":"COVID-19-associated coagulopathy and disseminated intravascular coagulation","volume":"113","author":"Asakura","year":"2021","journal-title":"Int J Hematol"},{"key":"R29-5-20240906","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/dyab012","article-title":"The role of C-reactive protein as a prognostic marker in COVID-19","volume":"17","author":"Stringer","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R30-5-20240906","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"R31-5-20240906","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-010-0129-9","article-title":"Recent advances in the treatment of mucormycosis","volume":"12","author":"Spellberg","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"R32-5-20240906","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/194589240101500508","article-title":"Treatment of rhinoc- erebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B","volume":"15","author":"Alobid","year":"2001","journal-title":"Am J Rhinol"},{"key":"R33-5-20240906","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1469-0691.2009.02989.x","article-title":"Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: Perspectives from maxillofacial surgeon","volume":"15","author":"Rapidis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R34-5-20240906","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0030-6665(00)80010-9","article-title":"Mucormycosis of the nose and paranasal sinuses","volume":"33","author":"Ferguson","year":"2000","journal-title":"Otolaryngol Clin North Am"},{"key":"R35-5-20240906","first-page":"146","article-title":"Palate ulcer due to mucormycosis","volume":"16","author":"Kyrmizakis","year":"2002","journal-title":"J Laryngol Otol"},{"key":"R36-5-20240906","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00405-005-0919-0","article-title":"Rhinocerebral mucormycosis: Pathways of spread","volume":"262","author":"Hosseini","year":"2005","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R37-5-20240906","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1055\/s-0039-1695713","article-title":"Reconstruction of head and neck mucormycosis: A literature review and own experience in immediate reconstruction","volume":"4","author":"Palacios","year":"2019","journal-title":"J Reconstr Microsurg Open"},{"key":"R38-5-20240906","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcms.2012.03.019","article-title":"The surgical management of rhinocerebral mucormycosis","volume":"41","author":"El-Naaj","year":"2013","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_152_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:51Z","timestamp":1787166591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_152_22"}},"subtitle":["A Single Hospital-Based Study"],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_152_22","relation":{},"ISSN":["0973-029X"],"issn-type":[{"value":"0973-029X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}